Eritel-LN 40mg 15 Tablets

babies: it does not apply to babies. lactating mothers: please consult your doctor before using this medicine. information regarding the use of this medicine during breastfeeding is not available.
pregnancy: it is unsafe to use this medicine during pregnancy. human studies suggest that there is a harmful effect on developing babies.
please consult your doctor before using this medicine. alcohol: it is unsafe to consume alcohol while using this medicine.
driving: this medicine may cause dizziness, sleepiness and affect your vision. if you experience these symptoms, do not drive.
liver: this medicine should be used with caution in patients with liver disease. dose adjustment is needed.
please consult your doctor before using this medicine. it is not recommended in patients with severe liver disease. kidney: please consult your doctor before using this medicine.
limited information is available on the use of this medicine in patients with kidney disease. .

Dizziness Headache Tiredness Ankle swelling Flushing Increased potassium level in blood Stomach upset.

ERITEL-LN is a combination medicine used in the treatment of hypertension. cilnidipine is a calcium channel blocker, and telmisartan is an angiotensin receptor blocker.
they both work by relaxing the blood vessels and make it easier for the heart to pump blood around the body. this combination of medicine reduces blood pressure effectively..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• take the ERITEL-LN medicine with or without food as long as prescribed by your doctor • do not stop taking this medicine without consulting your doctor • if you experience dizziness, headache, ankle swelling, and increased potassium levels in the blood, inform your doctor • avoid consumption of alcohol while taking this medicine as it may enhance the blood pressure-lowering effect of this medicine • to get better results to take this medicine at a fixed time regularly.

• telmisartan + ramipril: concurrent use leads to an increase in the risk of low blood pressure • cilnidipine + abametapir: concurrent use leads to an increase in the therapeutic effect of cilnidipine • cilnidipine + adenosine: concurrent use leads to an increase in the risk of irregular heartbeat • telmisartan + spironolactone: concurrent use leads to an increase in the risk of potassium levels • telmisartan + trimethoprim: concurrent use leads to an increase in the risk of potassium levels.